By 2026 that figure had risen to 11.4% meaning roughly one in nine dollars of employer drug spending now goes to this single medication class
Zepbound (tirzepatide) Approved - A once-weekly injectable medication approved by the FDA in November 2023 for chronic weight management
Self-injection in the upper arm is difficult
Retatrutide adds a third receptor, glucagon, creating what researchers call a triple agonist
5-8 Recommended tests include: Vitamin B12 and methylmalonic acid Serum folate Ferritin, serum iron, and TIBC Serum or RBC magnesium 25-hydroxy vitamin D Serum zinc Whole blood thiamine or erythrocyte transketolase Vitamins A, E, and K1 in high-risk individuals Comprehensive metabolic panel for electrolyte status In complex or refractory cases, advanced micronutrient testing from functional laboratories may be warranted
Customs brokerage fees, if you use a specialized freight forwarder, add another 50-200 dollars